Barclays’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Barclays’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-130,434	Closed	-$8.88M	–	4808
2022 Q3	$8.88M	Sell	130,434 -461,042	-78%	-$31.4M	0.01%	858
2022 Q2	$18.9M	Buy	591,476 +530,438	+869%	+$16.9M	0.01%	612
2022 Q1	$2.11M	Sell	61,038 -14,150	-19%	-$490K	﹤0.01%	1737
2021 Q4	$2.2M	Sell	75,188 -5,516	-7%	-$161K	﹤0.01%	1759
2021 Q3	$2.06M	Sell	80,704 -16,067	-17%	-$410K	﹤0.01%	1854
2021 Q2	$3.39M	Buy	96,771 +20,722	+27%	+$725K	﹤0.01%	1412
2021 Q1	$3.1M	Sell	76,049 -34,692	-31%	-$1.41M	﹤0.01%	1546
2020 Q4	$4.8M	Buy	110,741 +38,144	+53%	+$1.65M	﹤0.01%	1038
2020 Q3	$4M	Buy	72,597 +61,898	+579%	+$3.41M	﹤0.01%	1083
2020 Q2	$675K	Sell	10,699 -85,008	-89%	-$5.36M	﹤0.01%	2155
2020 Q1	$4.89M	Sell	95,707 -46,892	-33%	-$2.4M	﹤0.01%	880
2019 Q4	$11.3M	Buy	142,599 +109,179	+327%	+$8.68M	0.01%	792
2019 Q3	$1.62M	Sell	33,420 -22,258	-40%	-$1.08M	﹤0.01%	1924
2019 Q2	$2.93M	Buy	55,678 +38,015	+215%	+$2M	﹤0.01%	1492
2019 Q1	$935K	Sell	17,663 -1,574	-8%	-$83.3K	﹤0.01%	2192
2018 Q4	$789K	Sell	19,237 -21,793	-53%	-$894K	﹤0.01%	1975
2018 Q3	$1.56M	Buy	41,030 +35,736	+675%	+$1.36M	﹤0.01%	1965
2018 Q2	$239K	Sell	5,294 -24,873	-82%	-$1.12M	﹤0.01%	2660
2018 Q1	$1.46M	Sell	30,167 -61,626	-67%	-$2.98M	﹤0.01%	1552
2017 Q4	$3.61M	Sell	91,793 -511	-0.6%	-$20.1K	﹤0.01%	987
2017 Q3	$2.87M	Sell	92,304 -1,472	-2%	-$45.7K	﹤0.01%	1045
2017 Q2	$2.57M	Sell	93,776 -3,604	-4%	-$98.6K	﹤0.01%	1098
2017 Q1	$3.59M	Buy	97,380 +70,057	+256%	+$2.58M	﹤0.01%	907
2016 Q4	$394K	Buy	27,323 +24,532	+879%	+$354K	﹤0.01%	1962
2016 Q3	$64K	Buy	2,791 +381	+16%	+$8.74K	﹤0.01%	2631
2016 Q2	$40K	Buy	+2,410	New	+$40K	﹤0.01%	2647
2015 Q4	–	Sell	-1,620	Closed	-$68K	–	3893
2015 Q3	$68K	Buy	+1,620	New	+$68K	﹤0.01%	2489